| 1 | Study | 1.5% | |
| 2 | Cancer | 1.24% | |
| 3 | Health | 1.04% | |
| 4 | New | 0.9% | |
| 5 | Disease | 0.79% | |
| 6 | Patients | 0.68% | |
| 7 | BMC | 0.64% | |
| 8 | Case | 0.59% | |
| 9 | Report | 0.48% | |
| 10 | HIV | 0.43% | |
| 11 | May | 0.43% | |
| 12 | Africa | 0.36% | |
| 13 | Treatment | 0.36% | |
| 14 | Risk | 0.34% | |
| 15 | Breast | 0.32% | |
| 16 | MD | 0.3% | |
| 17 | Clinical | 0.3% | |
| 18 | COVID-19 | 0.29% | |
| 19 | Liver | 0.29% | |
| 20 | Syndrome | 0.29% | |
| 21 | Infectious | 0.29% | |
| 22 | AI | 0.27% | |
| 23 | Trial | 0.27% | |
| 24 | Review | 0.27% | |
| 25 | Heart | 0.25% | |
| 26 | Diabetes | 0.25% | |
| 27 | Parkinsons | 0.25% | |
| 28 | Patient | 0.25% | |
| 29 | Rare | 0.23% | |
| 30 | World | 0.21% | |
| 31 | Acute | 0.21% | |
| 32 | Vaccine | 0.21% | |
| 33 | Use | 0.2% | |
| 34 | Brain | 0.2% | |
| 35 | Prostate | 0.2% | |
| 36 | Shows | 0.2% | |
| 37 | Alzheimers | 0.2% | |
| 38 | Development | 0.2% | |
| 39 | Research | 0.2% | |
| 40 | Human | 0.2% | |
| 41 | Against | 0.2% | |
| 42 | Not | 0.2% | |
| 43 | Therapy | 0.2% | |
| 44 | Data | 0.18% | |
| 45 | Diagnosis | 0.18% | |
| 46 | Care | 0.18% | |
| 47 | China | 0.18% | |
| 48 | Children | 0.18% | |
| 49 | Chronic | 0.18% | |
| 50 | Type | 0.18% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
Case Study: Advise Patients on Eligibility, Efficacy of Zoster Vaccine
Pharmacy Times
2024-04-22 22:59:53
Consistent Efficacy of Eptinezumab as Migraine Prevention Treatment: Jessica Ailani, MD
Neurology Live
2024-04-22 21:11:54
Variable-Sequenced Large-Spot KTP and PDL Demonstrate Comparable Efficacy in Rosacea
Dermatology Times
2024-04-19 00:19:27
Oncology Learning Network
2024-04-18 22:47:02
European Union
2024-04-17 21:03:09